Glycemic control among patients in China with type 2 diabetes mellitus receiving oral drugs or injectables
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The prevalence of type 2 diabetes mellitus (T2DM) is increasing rapidly among Chinese adults, and limited data are available on T2DM management and the status of glycemic control in China. We assessed the efficacy of oral antidiabetes drugs (OADs), glucagon-like peptide-1 (GLP-1) receptor agonists, and insulin for treatment of T2DM across multiple regions in China. METHODS: This was a multicenter, cross-sectional survey of outpatients conducted in 606 hospitals across China. Data from all the patients were collected between April and June, 2011. RESULTS: A total of 238,639 patients were included in the survey. Eligible patients were treated with either OADs alone (n=157,212 [65.88%]), OADs plus insulin (n=80,973 [33.93%]), or OADs plus GLP-1 receptor agonists (n=454 [0.19%]). The OAD monotherapy, OAD + insulin, and OAD + GLP-1 receptor agonist groups had mean glycosylated hemoglobin (HbA1c) levels (±SD) of 7.67% (±1.58%), 8.21% (±1.91%), and 7.80% (±1.76%), respectively. Among those three groups, 34.63%, 26.21%, and 36.12% met the goal of HbA1c <7.0%, respectively. Mean HbA1c and achievement of A1c <7.0% was related to the duration of T2DM. CONCLUSIONS: Less than one third of the patients had achieved the goal of HbA1c <7.0%. Glycemic control decreased and insulin use increased with the duration of diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Standards of medical care in diabetes—2013
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc13-s011 · Cited by 4,369
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2012) · Diabetologia · doi:10.1007/s00125-012-2534-0 · Cited by 3,919
Prevalence of Diabetes among Men and Women in China
Yang, W., Lu, J., Weng, J., Jia, W., Ji, L., Xiao, J., Shan, Z., Liu, J., Tian, H., Ji, Q., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908292 · Cited by 3,031 · cited 2×
“T Commons Attribution License (http://creativec reproduction in any medium, provided the or for subjects ≥20 years old [2,3].”
BackgroundSelf-citationSkyler, J. S., Bergenstal, R., Bonow, R. O., Buse, J., Deedwania, P., Gale, E. A. M., Howard, B. V., Kirkman, M. S., Kosiborod, M., Reaven, P., et al. (2009) · Diabetes Care · doi:10.2337/dc08-9026 · Cited by 881
Cited by
Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis
Zhang, P., Lu, J., Jing, Y., Tang, S., Zhu, D., & Bi, Y. (2017) · Annals of Medicine · doi:10.1080/07853890.2016.1231932 · Cited by 1,853
Self-citationBabineaux, S. M., Curtis, B., Holbrook, T., Milligan, G., & Piercy, J. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-010352 · Cited by 253
Rosenstock, J., Emral, R., Sauque-Reyna, L., Mohan, V., Trescolí, C., Al Sifri, S., Lalic, N., Alvarez, A., Picard, P., Bonnemaire, M., et al. (2021) · Diabetes Care · doi:10.2337/dc21-0393 · Cited by 63
“Despite this, premix insulins are widely used globally, particularly in Asia, Africa, the Middle East, China and some EU countries (8-11).”
BackgroundJi, L., Su, Q., Feng, B., Shan, Z., Hu, R., Xing, X., & Xue, Y. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.08.005 · Cited by 43
“0% (53 mmol/mol) [21].”
BackgroundSelf-citationXia, S.-F., Maitiniyazi, G., Chen, Y., Wu, X.-Y., Zhang, Y., Zhang, X.-Y., Li, Z.-Y., Liu, Y., Qiu, Y.-Y., & Wang, J. (2022) · JMIR mhealth and uhealth · doi:10.2196/30571 · Cited by 40
Metadata
- Authors
- Ji, L.-N., Lu, J.-M., Guo, X.-H., Yang, W.-Y., Weng, J.-P., Jia, W.-P., Zou, D.-J., Zhou, Z.-G., Yu, D.-M., Liu, J., Shan, Z.-Y., Yang, Y.-Z., Hu, R.-M., Zhu, D.-L., Yang, L.-Y., Chen, L., Zhao, Z.-G., Li, Q.-F., Tian, H.-M., Ji, Q.-H., Liu, J., Ge, J.-P., Shi, L.-X., & Xu, Y.-C.
- Venue
- BMC Public Health
- Published
- 2013-06-21
- Volume
- 13
- Issue
- 1
- Pages
- 602-602
- ISSN
- 1471-2458 (ISSN-L)
- OpenAlex
- W2036709932
- Cited by
- 142
- References
- 5
- FWCI
- 9.43
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Glycemic control among patients in China with type 2 diabetes mellitus receiving oral drugs or injectables. https://app.cochat.ai/papers/10.1186/1471-2458-13-602
- The paper
- Ji, L.-N., Lu, J.-M., Guo, X.-H., Yang, W.-Y., Weng, J.-P., Jia, W.-P., Zou, D.-J., Zhou, Z.-G., Yu, D.-M., Liu, J., Shan, Z.-Y., Yang, Y.-Z., Hu, R.-M., Zhu, D.-L., Yang, L.-Y., Chen, L., Zhao, Z.-G., Li, Q.-F., Tian, H.-M., . . . Xu, Y.-C. (2013). Glycemic control among patients in China with type 2 diabetes mellitus receiving oral drugs or injectables. BMC Public Health. https://doi.org/10.1186/1471-2458-13-602
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.